Nobivac® Tricat Trio

Description:

Active immunisation of cats to reduce clinical signs and virus excretion caused by infection with feline calicivirus and/or feline rhinotracheitis virus and to prevent clinical signs, virus excretion and leucopenia caused by feline panleucopenia virus. The duration of immunity is 1 year for the FCV and FVR components; 3 years for the FPLV component.

Composition

Per dose of 1 ml reconstituted vaccine:
Live attenuated feline calicivirus, strain F9 at least 4.6 log₁₀ PFU*
Live attenuated feline rhinotracheitis virus, strain G2620A at least 5.2 log₁₀ PFU*
Live attenuated feline panleucopenia virus, strain MW-1 at least 4.3 log₁₀ TCID₅₀**
* plaque forming units
** tissue culture infectious dose

Indications for use:

Active immunisation of cats to reduce clinical signs and virus excretion caused by infection with feline calicivirus and/or feline rhinotracheitis virus and to prevent clinical signs, virus excretion and leucopenia caused by feline panleucopenia virus.

Contraindications:

Use during pregnancy and lactation:
As this product has not been tested in pregnant queens and during lactation, vaccination during pregnancy and lactation is not recommended.

Storage:

Vaccine: Store at 2-8°C. Protect from light.
Solvent: Can be stored at 15-25°C if stored independently from the vaccine.

Presentation:

One box contains 5 vials of dose and 5 vials of solvent

Refer to Product Leaflet for more information.